DNLI
Price
$14.70
Change
+$0.48 (+3.38%)
Updated
Jun 6 closing price
Capitalization
2.14B
54 days until earnings call
NRSN
Price
$1.79
Change
+$0.07 (+4.07%)
Updated
Jun 6 closing price
Capitalization
42.94M
81 days until earnings call
Interact to see
Advertisement

DNLI vs NRSN

Header iconDNLI vs NRSN Comparison
Open Charts DNLI vs NRSNBanner chart's image
Denali Therapeutics
Price$14.70
Change+$0.48 (+3.38%)
Volume$1.79M
Capitalization2.14B
NeuroSense Therapeutics
Price$1.79
Change+$0.07 (+4.07%)
Volume$149.39K
Capitalization42.94M
DNLI vs NRSN Comparison Chart
Loading...
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DNLI vs. NRSN commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNLI is a Hold and NRSN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (DNLI: $14.70 vs. NRSN: $1.79)
Brand notoriety: DNLI and NRSN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DNLI: 119% vs. NRSN: 77%
Market capitalization -- DNLI: $2.14B vs. NRSN: $42.94M
DNLI [@Biotechnology] is valued at $2.14B. NRSN’s [@Biotechnology] market capitalization is $42.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DNLI’s FA Score shows that 0 FA rating(s) are green whileNRSN’s FA Score has 0 green FA rating(s).

  • DNLI’s FA Score: 0 green, 5 red.
  • NRSN’s FA Score: 0 green, 5 red.
According to our system of comparison, both DNLI and NRSN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DNLI’s TA Score shows that 4 TA indicator(s) are bullish while NRSN’s TA Score has 7 bullish TA indicator(s).

  • DNLI’s TA Score: 4 bullish, 5 bearish.
  • NRSN’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, NRSN is a better buy in the short-term than DNLI.

Price Growth

DNLI (@Biotechnology) experienced а +11.03% price change this week, while NRSN (@Biotechnology) price change was +16.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

DNLI is expected to report earnings on Jul 31, 2025.

NRSN is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DNLI($2.14B) has a higher market cap than NRSN($42.9M). NRSN YTD gains are higher at: 49.167 vs. DNLI (-27.870). NRSN has higher annual earnings (EBITDA): -10.41M vs. DNLI (-505.16M). DNLI has more cash in the bank: 818M vs. NRSN (344K). NRSN has less debt than DNLI: NRSN (19K) vs DNLI (48.6M). DNLI (0) and NRSN (0) have equivalent revenues.
DNLINRSNDNLI / NRSN
Capitalization2.14B42.9M4,979%
EBITDA-505.16M-10.41M4,851%
Gain YTD-27.87049.167-57%
P/E RatioN/AN/A-
Revenue00-
Total Cash818M344K237,791%
Total Debt48.6M19K255,789%
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
40
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
98
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DNLINRSN
RSI
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 18 days ago
78%
Bullish Trend 1 day ago
88%
Declines
ODDS (%)
Bearish Trend 10 days ago
80%
Bearish Trend 16 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
DNLI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRSN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTBR15.751.06
+7.22%
Lightbridge Corp
IESC279.989.18
+3.39%
IES Holdings
EGHT1.810.04
+2.26%
8x8
APD279.783.56
+1.29%
Air Products & Chemicals
UNIT4.350.04
+0.93%
Uniti Group

DNLI and

Correlation & Price change

A.I.dvisor indicates that over the last year, DNLI has been loosely correlated with NRIX. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if DNLI jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNLI
1D Price
Change %
DNLI100%
+3.38%
NRIX - DNLI
56%
Loosely correlated
+2.24%
BEAM - DNLI
55%
Loosely correlated
+9.26%
ARWR - DNLI
54%
Loosely correlated
+2.13%
RGNX - DNLI
53%
Loosely correlated
+14.95%
ABCL - DNLI
52%
Loosely correlated
+2.95%
More

NRSN and

Correlation & Price change

A.I.dvisor tells us that NRSN and SLRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NRSN and SLRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NRSN
1D Price
Change %
NRSN100%
+4.07%
SLRX - NRSN
32%
Poorly correlated
-4.12%
CTMX - NRSN
31%
Poorly correlated
+10.00%
DNLI - NRSN
29%
Poorly correlated
+3.38%
VKTX - NRSN
27%
Poorly correlated
+2.92%
KANT - NRSN
27%
Poorly correlated
+8.49%
More